For drug treatment of
Drosophila, flies were collected after eclosion and divided into separate vials (20~25 flies each vial). Instant fly food (Carolina) was mixed with 1% H2O2 (cat#: H1009, Sigma-Aldrich), 250 μM
rotenone (cat#: R8875, Sigma-Aldrich) or 100 μM CCCP (cat#: C2759, Sigma-Aldrich). Vials were changed every day. Samples were collected for further analyses after 5 days of treatment. In order to achieve high efficiency, anisomycin stock (100mM in DMSO, cat#: A9789, Sigma-Aldrich) were diluted with the
Schneider’s Medium (cat#: 21720–024, GIBCO™) to 250 μM and injected into fly thorax between mesonotum and scutellum via a hand-made glass needle. After injection, flies were kept in the vial with standard fly food and waited for 24 hours (short-term) before the experiments, and for long-term (7 days) treatment, three injections (day0, day3, day6) were applied to newly eclosed flies.
For drug treatment in human cells, HeLa cells or HeLa/GFP-Parkin cells were cultured and treated with CCCP at the indicated concentrations and durations as described (Narendra et al., 2010 (
link)). For most experiments, 20 μM CCCP concentration was used. For Antimycin/Oligomycin treatment, 10 μM of each compound was used. For anisomycin, 200 μM was used, and for the VCP inhibitor
NMS-873 (cat#: S7285, Selleckchem), 1 μM was used.
Wu Z., Tantray I., Lim J., Chen S., Li Y., Davis Z., Sitron C., Dong J., Gispert S., Auburger G., Brandman O., Bi X., Snyder M, & Lu B. (2019). MISTERMINATE Mechanistically Links Mitochondrial Dysfunction with Proteostasis Failure. Molecular cell, 75(4), 835-848.e8.